249 related articles for article (PubMed ID: 16384980)
1. Retinal thickness and subnormal retinal oxygenation response in experimental diabetic retinopathy.
Luan H; Roberts R; Sniegowski M; Goebel DJ; Berkowitz BA
Invest Ophthalmol Vis Sci; 2006 Jan; 47(1):320-8. PubMed ID: 16384980
[TBL] [Abstract][Full Text] [Related]
2. Drug intervention can correct subnormal retinal oxygenation response in experimental diabetic retinopathy.
Berkowitz BA; Roberts R; Luan H; Peysakhov J; Knoerzer DL; Connor JR; Hohman TC
Invest Ophthalmol Vis Sci; 2005 Aug; 46(8):2954-60. PubMed ID: 16043871
[TBL] [Abstract][Full Text] [Related]
3. Subnormal retinal oxygenation response precedes diabetic-like retinopathy.
Berkowitz BA; Kowluru RA; Frank RN; Kern TS; Hohman TC; Prakash M
Invest Ophthalmol Vis Sci; 1999 Aug; 40(9):2100-5. PubMed ID: 10440266
[TBL] [Abstract][Full Text] [Related]
4. Correction of early subnormal superior hemiretinal DeltaPO(2) predicts therapeutic efficacy in experimental diabetic retinopathy.
Berkowitz BA; Ito Y; Kern TS; McDonald C; Hawkins R
Invest Ophthalmol Vis Sci; 2001 Nov; 42(12):2964-9. PubMed ID: 11687543
[TBL] [Abstract][Full Text] [Related]
5. Impaired apparent ion demand in experimental diabetic retinopathy: correction by lipoic Acid.
Berkowitz BA; Roberts R; Stemmler A; Luan H; Gradianu M
Invest Ophthalmol Vis Sci; 2007 Oct; 48(10):4753-8. PubMed ID: 17898301
[TBL] [Abstract][Full Text] [Related]
6. alpha-lipoic acid corrects late-phase supernormal retinal oxygenation response in experimental diabetic retinopathy.
Roberts R; Luan H; Berkowitz BA
Invest Ophthalmol Vis Sci; 2006 Sep; 47(9):4077-82. PubMed ID: 16936127
[TBL] [Abstract][Full Text] [Related]
7. Early supernormal retinal oxygenation response in patients with diabetes.
Trick GL; Edwards P; Desai U; Berkowitz BA
Invest Ophthalmol Vis Sci; 2006 Apr; 47(4):1612-9. PubMed ID: 16565400
[TBL] [Abstract][Full Text] [Related]
8. Blocking ET-1 receptors does not correct subnormal retinal oxygenation response in experimental diabetic retinopathy.
Roberts R; Luan H; Berkowitz BA
Invest Ophthalmol Vis Sci; 2006 Aug; 47(8):3550-5. PubMed ID: 16877428
[TBL] [Abstract][Full Text] [Related]
9. Significant reduction of the panretinal oxygenation response after 28% supplemental oxygen recovery in experimental ROP.
Berkowitz BA; Zhang W
Invest Ophthalmol Vis Sci; 2000 Jun; 41(7):1925-31. PubMed ID: 10845618
[TBL] [Abstract][Full Text] [Related]
10. MRI retinovascular studies in humans: research in patients with diabetes.
Trick GL; Edwards PA; Desai U; Morton PE; Latif Z; Berkowitz BA
NMR Biomed; 2008 Nov; 21(9):1003-12. PubMed ID: 18821575
[TBL] [Abstract][Full Text] [Related]
11. Intravitreal injection of corticosteroid attenuates leukostasis and vascular leakage in experimental diabetic retina.
Tamura H; Miyamoto K; Kiryu J; Miyahara S; Katsuta H; Hirose F; Musashi K; Yoshimura N
Invest Ophthalmol Vis Sci; 2005 Apr; 46(4):1440-4. PubMed ID: 15790913
[TBL] [Abstract][Full Text] [Related]
12. Noninvasive and simultaneous imaging of layer-specific retinal functional adaptation by manganese-enhanced MRI.
Berkowitz BA; Roberts R; Goebel DJ; Luan H
Invest Ophthalmol Vis Sci; 2006 Jun; 47(6):2668-74. PubMed ID: 16723485
[TBL] [Abstract][Full Text] [Related]
13. High-salt loading exacerbates increased retinal content of aquaporins AQP1 and AQP4 in rats with diabetic retinopathy.
Qin Y; Xu G; Fan J; Witt RE; Da C
Exp Eye Res; 2009 Nov; 89(5):741-7. PubMed ID: 19596320
[TBL] [Abstract][Full Text] [Related]
14. [Morphological changes of retina after N-methyl-D-aspartate induced damage in rats].
Shi JM; Jiang YQ; Liu XY
Zhong Nan Da Xue Xue Bao Yi Xue Ban; 2004 Jun; 29(3):287-91. PubMed ID: 16136962
[TBL] [Abstract][Full Text] [Related]
15. Intravitreal injection of exendin-4 analogue protects retinal cells in early diabetic rats.
Zhang Y; Zhang J; Wang Q; Lei X; Chu Q; Xu GT; Ye W
Invest Ophthalmol Vis Sci; 2011 Jan; 52(1):278-85. PubMed ID: 20688733
[TBL] [Abstract][Full Text] [Related]
16. Effect of memantine on neuroretinal function and retinal vascular changes of streptozotocin-induced diabetic rats.
Kusari J; Zhou S; Padillo E; Clarke KG; Gil DW
Invest Ophthalmol Vis Sci; 2007 Nov; 48(11):5152-9. PubMed ID: 17962468
[TBL] [Abstract][Full Text] [Related]
17. Erythropoietin protects retinal neurons and glial cells in early-stage streptozotocin-induced diabetic rats.
Zhu B; Wang W; Gu Q; Xu X
Exp Eye Res; 2008 Feb; 86(2):375-82. PubMed ID: 18191124
[TBL] [Abstract][Full Text] [Related]
18. Normalization of retinal vascular permeability in experimental diabetes with genistein.
Nakajima M; Cooney MJ; Tu AH; Chang KY; Cao J; Ando A; An GJ; Melia M; de Juan E
Invest Ophthalmol Vis Sci; 2001 Aug; 42(9):2110-4. PubMed ID: 11481279
[TBL] [Abstract][Full Text] [Related]
19. Purinergic receptor activation inhibits osmotic glial cell swelling in the diabetic rat retina.
Wurm A; Iandiev I; Hollborn M; Wiedemann P; Reichenbach A; Zimmermann H; Bringmann A; Pannicke T
Exp Eye Res; 2008 Oct; 87(4):385-93. PubMed ID: 18687327
[TBL] [Abstract][Full Text] [Related]
20. Neuroprotective effect and intraocular penetration of nipradilol, a beta-blocker with nitric oxide donative action.
Mizuno K; Koide T; Yoshimura M; Araie M
Invest Ophthalmol Vis Sci; 2001 Mar; 42(3):688-94. PubMed ID: 11222528
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
